Prospective evaluation of plasma Epstein–Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma

BACKGROUND: Plasma Epstein–Barr virus (pEBV) DNA and fluorodeoxyglucose positron emission (PET) reflect tumour burden in advanced NPC. This study hypothesised that a dual endpoint based on assessing pEBV DNA clearance and PET response could predict early drug response. METHODS: Eligible patients und...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Ma, Brigette, Hui, Edwin P, King, Ann, Leung, Sing F, Kam, Michael KM, Mo, Frankie, Li, Leung, Wang, Ki, Loong, Herbert, Wong, Ashley, Chan, Charles ML, Chan, KC Allen, Wong, SC Cesar, Lo, YM Dennis, Chan, Anthony TC
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5931094/
https://ncbi.nlm.nih.gov/pubmed/29555989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0026-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados